（Wriiten By WAN.H.Y & SONG.X.W Translated By YU.Y.C）On August 22, China's first disease-based medical artificial intelligence model -- Lingxi Medical cerebrovascular disease specific large model, led by Professor Wujian's team in the Department of Neurology of Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University, was officially released. This model marks another breakthrough of digital diagnosis and treatment technology in the medical field, and brings a new paradigm for the standardized diagnosis and treatment of cerebrovascular diseases, personalized treatment and clinical research.
As one of the major chronic diseases that harm human health, cerebrovascular disease has the characteristics of high morbidity, high prevalence, high mortality and high recurrence rate. However, due to the uneven distribution of medical resources, there is still a shortage of doctors in some areas, and the level of diagnosis and treatment is uneven, resulting in patients can not get timely and effective treatment.
Lingxi Medical cerebrovascular disease specific large model is built on the basis of massive cerebrovascular disease clinical medical data. After six months of careful training by AI engineers and cerebrovascular disease experts, it has excellent professional concept understanding, complex reasoning and logical judgment ability, and can provide doctors with accurate medical guidance and personalized treatment plans, effectively improve the standardized level of diagnosis and treatment, and improve patient prognosis.
Professor Wong Tien Yin, Vice Provost of Tsinghua University and Director of the School of Medicine, Wu Jian，Pi Jingtao, neurologist of Beijing Tsinghua Changgung Hospital, attended the conference and made speeches or presentations. The release of Lingxi Medical cerebrovascular disease specific large model is not only a major leap in the application of medical artificial intelligence in the standardized diagnosis and treatment of cerebrovascular diseases, but also a new starting point for the digital transformation of the medical industry. The application of large models is not only limited to the field of cerebrovascular diseases, but will also be extended to other specialized diseases and multidisciplinary fields in the future, helping the intelligent process of scientific research and disease prediction. Through continuous optimization and application promotion, the Model will provide more innovative solutions for the medical industry and promote the innovative development of the medical and health industry.